000291765 001__ 291765
000291765 005__ 20241219142546.0
000291765 0247_ $$2doi$$a10.1007/s00120-024-02389-1
000291765 0247_ $$2pmid$$apmid:39023637
000291765 0247_ $$2ISSN$$a2731-7064
000291765 0247_ $$2ISSN$$a2731-7072
000291765 037__ $$aDKFZ-2024-01501
000291765 041__ $$aGerman
000291765 082__ $$a610
000291765 1001_ $$0P:(DE-He78)79897f8897ff77676549d9895258a0f2$$aRadtke, Jan Philipp$$b0$$eFirst author$$udkfz
000291765 245__ $$aERSPC trial-prostate-specific antigen (PSA)-based prostate cancer screening in older men.[ERSPC-Studie – PSA(prostataspezifisches Antigen)-basiertes Prostatakarzinom-Screening bei älteren Patienten].
000291765 260__ $$aNew York]$$bSpringer Medizin$$c2024
000291765 3367_ $$2DRIVER$$aarticle
000291765 3367_ $$2DataCite$$aOutput Types/Journal article
000291765 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1732099467_11919
000291765 3367_ $$2BibTeX$$aARTICLE
000291765 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000291765 3367_ $$00$$2EndNote$$aJournal Article
000291765 500__ $$a#EA:E010#LA:C130# /  Volume 63, pages 1155–1157, (2024)
000291765 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000291765 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000291765 7001_ $$aHandke, Analena Elisa$$b1
000291765 7001_ $$aHaidl, Friederike$$b2
000291765 7001_ $$0P:(DE-He78)f84639cbc39bc20ecda8d00e6de97578$$aAlbers, Peter$$b3$$eLast author$$udkfz
000291765 773__ $$0PERI:(DE-600)3123197-4$$a10.1007/s00120-024-02389-1$$p1155–1157$$tDie Urologie$$v63$$x2731-7064$$y2024
000291765 8564_ $$uhttps://inrepo02.dkfz.de/record/291765/files/s00120-024-02389-1.pdf
000291765 8564_ $$uhttps://inrepo02.dkfz.de/record/291765/files/s00120-024-02389-1.pdf?subformat=pdfa$$xpdfa
000291765 909CO $$ooai:inrepo02.dkfz.de:291765$$pVDB
000291765 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)79897f8897ff77676549d9895258a0f2$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000291765 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f84639cbc39bc20ecda8d00e6de97578$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000291765 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000291765 9141_ $$y2024
000291765 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-08-22$$wger
000291765 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-08-22$$wger
000291765 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-22
000291765 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-22
000291765 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-22
000291765 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-08-22
000291765 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-08-22
000291765 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-22
000291765 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-08-22
000291765 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-08-22
000291765 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-08-22
000291765 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bUROLOGIE : 2022$$d2023-08-22
000291765 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-08-22
000291765 9202_ $$0I:(DE-He78)C130-20160331$$kC130$$lPersonalisierte Früherkennung des Prostatakarzinoms$$x0
000291765 9201_ $$0I:(DE-He78)E010-20160331$$kE010$$lE010 Radiologie$$x0
000291765 9201_ $$0I:(DE-He78)C130-20160331$$kC130$$lPersonalisierte Früherkennung des Prostatakarzinoms$$x1
000291765 9200_ $$0I:(DE-He78)E010-20160331$$kE010$$lE010 Radiologie$$x0
000291765 980__ $$ajournal
000291765 980__ $$aVDB
000291765 980__ $$aI:(DE-He78)E010-20160331
000291765 980__ $$aI:(DE-He78)C130-20160331
000291765 980__ $$aUNRESTRICTED